Resolvin D1 drives establishment of Leishmania amazonensis infection.
about
Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance.Leishmania infantum lipophosphoglycan induced-Prostaglandin E2 production in association with PPAR-γ expression via activation of Toll like receptors-1 and 2.Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control
P2860
Resolvin D1 drives establishment of Leishmania amazonensis infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 April 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Resolvin D1 drives establishment of Leishmania amazonensis infection.
@en
Resolvin D1 drives establishment of Leishmania amazonensis infection.
@nl
type
label
Resolvin D1 drives establishment of Leishmania amazonensis infection.
@en
Resolvin D1 drives establishment of Leishmania amazonensis infection.
@nl
prefLabel
Resolvin D1 drives establishment of Leishmania amazonensis infection.
@en
Resolvin D1 drives establishment of Leishmania amazonensis infection.
@nl
P2093
P2860
P50
P356
P1433
P1476
Resolvin D1 drives establishment of Leishmania amazonensis infection.
@en
P2093
Aldina Barral
Bruno B Andrade
Christianne Bandeira-Melo
Hayna Malta-Santos
Jackson M Costa
Jaqueline França-Costa
P2860
P2888
P356
10.1038/SREP46363
P407
P577
2017-04-10T00:00:00Z